KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Other Working Capital Changes (2017 - 2025)

Historic Other Working Capital Changes for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to -$1.4 million.

  • Cardlytics' Other Working Capital Changes fell 75060.98% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 million, marking a year-over-year decrease of 1827.68%. This contributed to the annual value of -$1.4 million for FY2024, which is 4542.54% up from last year.
  • Per Cardlytics' latest filing, its Other Working Capital Changes stood at -$1.4 million for Q3 2025, which was down 75060.98% from $1.6 million recorded in Q2 2025.
  • Cardlytics' 5-year Other Working Capital Changes high stood at $3.4 million for Q1 2024, and its period low was -$3.1 million during Q2 2024.
  • Moreover, its 5-year median value for Other Working Capital Changes was -$164000.0 (2024), whereas its average is -$141631.6.
  • Per our database at Business Quant, Cardlytics' Other Working Capital Changes soared by 217450.98% in 2022 and then plummeted by 75060.98% in 2025.
  • Cardlytics' Other Working Capital Changes (Quarter) stood at $170000.0 in 2021, then plummeted by 682.94% to -$991000.0 in 2022, then crashed by 39.05% to -$1.4 million in 2023, then decreased by 15.31% to -$1.6 million in 2024, then rose by 12.21% to -$1.4 million in 2025.
  • Its last three reported values are -$1.4 million in Q3 2025, $1.6 million for Q2 2025, and $56000.0 during Q1 2025.